Summary:

«HotSpot Therapeutics, the allostery-focused biotech that works on what it calls “natural hotspots” — hence the name — is getting a bit hotter in its valuation from investors. And to that end they’ve raised $100 million.»

Article written by Paul Schloesser

29|11|2021

Source:

EndpointsNews

https://endpts.com/hotspot-gets-hotter-with-100m-raise-to-push-toward-clinic/